FOLH1 and nonpapillary renal cell carcinoma: The comprehensive evaluation of PSMA-targeted PET/CT in detecting ccRCC lesions assessed an optimal diagnostic performance in all the included papers, both on a per-lesion- and per-patient-based analyses in all the evaluated clinical settings without significant differences between PET/CT scans executed for staging or restaging [31].